{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiczdwcak77mi3vlqsbaefqamb7pdsl2h3mbkobf5lmgokz3q5m4l4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnaij3a4ejg2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvhx25kj53yvh3bfpgaejjaa7yzije624rs76ogsmrdkembq74yy"
    },
    "mimeType": "image/jpeg",
    "size": 462935
  },
  "path": "/news/2026-06-weight-loss-drugs-widening-health.html",
  "publishedAt": "2026-06-01T11:09:11.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and appropriate support, they could widen health inequalities in the UK, according to researchers at UCL and the University of Cambridge.",
  "title": "Weight loss drugs risk widening health inequalities, warn researchers"
}